Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study

BACKGROUND: The EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) trial has recently reported. OBJECTIVE: To assess the cost effectiveness of perindopril in stable coronary heart disease in the UK. METHODS: Clinical and resource use data were t...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Briggs, Andrew, Mihaylova, Borislava, Sculpher, Mark, Hall, Alistair, Wolstenholme, Jane, Simoons, Maarten, Deckers, Jaap, Ferrari, Roberto, Remme, Willem J, Bertrand, Michel, Fox, Kim
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 2007
Témata:
Coronary Artery Disease
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1955018/
https://ncbi.nlm.nih.gov/pubmed/17135223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2005.086728
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky